BUDGET IMPACT OF NEWLY APPROVED DRUGS BY THE SICILIAN DRUG FORMULARY COMMITTEE: AN INTRODUCTIVE ANALYSIS

被引：0
|
作者：
Aiello, A. [1 ]
D'Ausilio, A. [1 ]
Pizzimenti, V [2 ]
Formica, D. [2 ]
Sultana, J. [2 ]
Lucchesi, S. [3 ]
Ientile, V [2 ]
Toumi, M. [4 ]
Trifiro, G. [3 ]
机构：
[1] Creativ Ceut, Milan, Italy
[2] AOU Policlin G Martino, Messina, Italy
[3] Univ Messina, Messina, Italy
[4] Aix Marseille Univ, Marseille, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1631
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP97
引用
收藏
页码：A669 / A669
页数：1
相关论文
共 50 条
  • [31] Drug Prescribing Analysis: The Burden Of Orphan Drugs In A Tertiary Hospital Budget
    Lopes, Diogo Jose
    Borges-Carneiro, Filipa
    Souto, Miguel Torre
    Soares, Pedro
    Figueira, Luis
    Magro, Fernando
    Reina-Couto, Marta
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 203 - 203
  • [32] Absolute risk and cost of management of toxicities of newly approved anticancer drugs: A meta-analysis.
    Niraula, Saroj
    Amir, Eitan
    Emilio, Francisco
    Badillo, Vera
    Seruga, Bostjan
    Ocana, Alberto
    Tannock, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
    Miller, Jennifer E.
    Wilenzick, Marc
    Ritcey, Nolan
    Ross, Joseph S.
    Mello, Michelle M.
    BMJ OPEN, 2017, 7 (12):
  • [34] Analysis of estimated clinical benefit of newly approved drugs for US patients with acute myeloid leukemia
    Tran, Audrey A.
    Miljkovic, Milos
    Prasad, Vinay
    LEUKEMIA RESEARCH, 2020, 96
  • [35] The use of national reimbursement reports to support formulary decisions of the hospital’s Drug and Therapeutics Committee: a comparative analysis
    Barbara Claus
    Sabrina Commeyne
    Marc Van de Casteele
    Sylvie Rottey
    International Journal of Clinical Pharmacy, 2022, 44 : 769 - 774
  • [36] The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee: a comparative analysis
    Claus, Barbara
    Commeyne, Sabrina
    Van de Casteele, Marc
    Rottey, Sylvie
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 769 - 774
  • [37] Budget Impact Analysis of Antiepileptic Drugs for Lennox-Gastaut Syndrome
    Skornicki, Michelle
    Clements, Karen M. .
    O'Sullivan, Amy K.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (04): : 400 - 406
  • [38] BUDGET IMPACT ANALYSIS OF HEPATITIS C DRUGS IN MED-CAL
    Naku, F.
    VALUE IN HEALTH, 2015, 18 (03) : A224 - A224
  • [39] PHARMACOECONOMIC APPLICATIONS IN FORMULARY MANAGEMENT: BUDGET IMPACT ANALYSIS OF PACLITAXEL PROTEIN-BOUND AT A MAJOR CANCER CENTER
    Miller, L. A.
    Lau, J.
    Lal, L. S.
    Arbuckle, R.
    VALUE IN HEALTH, 2008, 11 (06) : A350 - A350
  • [40] The economic impact of introducing serotonin-noradrenaline reuptake inhibitors into the Brazilian national drug formulary - Cost-effectiveness and budget-impact analyses
    Machado, Marcio
    Iskedjian, Michael
    Ruiz, Ines A.
    Einarson, Thomas R.
    PHARMACOECONOMICS, 2007, 25 (11) : 979 - 990
12345